PDCD1LG2 and Autoimmunity: Expression is upregulated on activated T-cells and provides negative feedback to attenuate local T-cell responses in order to minimise collateral tissue damage and prevent autoimmunity by binding with its two known ligands PD-L1 or PD-L2 [27].